IMvigor 210, a phase II trial of atezolizumab (MPDL3280A) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC).

被引：32

作者：

Hoffman-Censits, Jean H.

Grivas, Petros

Van der Heijden, Michiel Simon

Dreicer, Robert

Loriot, Yohann

Retz, Margitta

Vogelzang, Nicholas J.

Perez-Gracia, Jose Luis

Rezazadeh, Arash

Bracarda, Sergio

Yu, Evan Y.

Hoimes, Christopher J.

Bellmunt, Joaquim

Quinn, David I.

Petrylak, Daniel Peter

Hussain, Syed A.

Cui, Na

Mariathasan, Sanjeev

Abidoye, Oyewale O.

Rosenberg, Jonathan E.

机构：

[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA

[2] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[3] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands

[4] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA

[5] Gustave Roussy, Dept Canc Med, Canc Campus, Villejuif, France

[6] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, Munich, Germany

[7] US Oncol Comprehens Canc Ctr Nevada, Las Vegas, NV USA

[8] Univ Navarra Clin, Dept Oncol, Pamplona, Spain

[9] Norton Canc Inst, Louisville, KY USA

[10] Osped San Donato USL8, Ist Toscano Tumori, Med Oncol, Arezzo, Italy

[11] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA

[12] Case Seidman Canc Ctr, Cleveland, OH USA

[13] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA

[14] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA

[15] Yale Canc Ctr, New Haven, CT USA

[16] Univ Liverpool, Clatterbridge Canc Ctr, Liverpool L69 3BX, Merseyside, England

[17] Genentech Inc, San Francisco, CA 94080 USA

[18] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA

[19] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 02期

关键词：

D O I：

10.1200/jco.2016.34.2_suppl.355

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

355

引用

页数：2